Online citations, reference lists, and bibliographies.
← Back to Search

The IKK NF-κB System: A Treasure Trove For Drug Development

M. Karin, Yumi Yamamoto, Q. M. Wang
Published 2004 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Nuclear factor-κB (NF-κB)/Rel transcription factors have been suspected since their discovery to play a pivotal role in chronic and acute inflammatory diseases. It now seems that aberrant regulation of NF-κB could also underlie autoimmune diseases and different types of cancer. Recently, NF-κB and the signalling pathways that regulate its activity have become a focal point for intense drug discovery and development efforts. Given the large number of major ailments in which aberrant regulation of NF-κB has been observed or is suspected, such efforts seem well justified. This review will discuss recent progress in the development of drugs that inhibit NF-κB activation, and consider their potential applications in inflammatory and autoimmune diseases, as well as cancer.
This paper references
10.1126/SCIENCE.8052854
Inhibition of NF-kappa B by sodium salicylate and aspirin.
E. Kopp (1994)
Inhibition of NF-κB by sodium salicylate and aspirin
E. Kopp (1994)
10.1073/PNAS.92.23.10599
Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
I. Alkalay (1995)
Stimulation-dependent IκB-α phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin–proteasome pathway
I Alkalay (1995)
Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.
J. Pierce (1996)
Rel/NF-kappaB/IkappaB proteins and cancer.
T. Gilmore (1996)
In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.
T. Blackwell (1996)
Rel/NF-κB/IκB proteins and cancer
T. D. Gilmore (1996)
Salicylates inhibit IκBα phosphorylation, endothelialleukocyte adhesion molecule expression, and neutrophil transmigration
J. W. Pierce (1996)
10.1074/JBC.272.33.20313
Protein Oxidation in Aging, Disease, and Oxidative Stress*
B. S. Berlett (1997)
10.1126/SCIENCE.275.5307.1787
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
P. Morin (1997)
10.1126/SCIENCE.275.5307.1790
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
B. Rubinfeld (1997)
10.1016/S0960-894X(97)10152-4
Novel cyanoguanidines with potent oral antitumour activity
C. Schou (1997)
10.1006/SCBI.1997.0061
Rel/NF-?B and I?B factors in oncogenesis
I. Luque (1997)
10.1056/NEJM199704103361506
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.
P. Barnes (1997)
Nuclear factor-κB — a pivotal transcription factor in chronic inflammatory diseases
P. J. Barnes (1997)
a potent and specific inhibitor of NF-κB
C. Wahl (1997)
Sulfasalazine : a potent and specific inhibitor of NF - κ B
C. Wahl (1997)
10.1111/j.1749-6632.1998.tb11119.x
Cytokine Gene Transcription By NF‐κB Family Members in Patients with Inflammatory Bowel Disease
M. Neurath (1998)
10.1038/34178
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
M. Ricote (1998)
10.1146/ANNUREV.IMMUNOL.16.1.225
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
S. Ghosh (1998)
10.1172/JCI992
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
C. Wahl (1998)
10.1038/26261
IKK-γ is an essential regulatory subunit of the IκB kinase complex
D. Rothwarf (1998)
10.1038/23948
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
M. Yin (1998)
10.1074/jbc.274.51.36631
Aminosalicylic Acid Inhibits IκB Kinase α Phosphorylation of IκBα in Mouse Intestinal Epithelial Cells*
F. Yan (1999)
10.1093/emboj/18.9.2401
An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin
M. Kitagawa (1999)
10.1126/SCIENCE.284.5412.316
Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase
Y. Hu (1999)
10.1074/jbc.274.37.26448
Inhibition of Interleukin-1-stimulated NF-κB RelA/p65 Phosphorylation by Mesalamine Is Accompanied by Decreased Transcriptional Activity*
L. Egan (1999)
10.1084/JEM.189.11.1839
The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis
Zhi-wei Li (1999)
10.1038/9550
Inducible cyclooxygenase may have anti-inflammatory properties
D. Gilroy (1999)
10.1074/jbc.274.38.27307
Sulindac Inhibits Activation of the NF-κB Pathway*
Yumi Yamamoto (1999)
10.1002/(SICI)1097-4644(19990915)74:4<606::AID-JCB10>3.0.CO;2-W
Suppression of TNFα‐mediated NFκb activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells
S. H. Tsai (1999)
10.1101/GAD.13.3.270
The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro
J. T. Winston (1999)
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.
P. J. Hjarnaa (1999)
10.1126/SCIENCE.284.5412.321
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Q. Li (1999)
10.1038/sj.onc.1202760
HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin
S. Fuchs (1999)
10.1146/ANNUREV.IMMUNOL.18.1.621
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
M. Karin (2000)
15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway
D. Straus (2000)
10.1073/PNAS.97.9.4844
15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
D. Straus (2000)
Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase.
M. Holmes-McNary (2000)
10.1126/SCIENCE.289.5484.1550
Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex
M. May (2000)
10.1016/S1097-2765(00)80262-2
Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.
C. Makris (2000)
β-carbolines の毛髪分析
植松 俊彦 (2000)
10.4049/jimmunol.165.12.7180
Vitamin C Inhibits NF-κB Activation by TNF Via the Activation of p38 Mitogen-Activated Protein Kinase1
A. Bowie (2000)
10.1038/47520
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
A. Rossi (2000)
the control of NF-κB activity
M. Karin (2000)
Phosphorylation meets ubiquitination : the control of NF - κ B activity
M. Karin (2000)
15-deoxy-∆12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
Straus (2000)
Antisense modulation of Inhibitor-κ B kinase-β gene expression WO
Isis Pharmaceuticals (2000)
10.1074/JBC.M100938200
Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity*
J. A. Keifer (2001)
10.1038/nm1201-1291
Possible new role for NF-κB in the resolution of inflammation
T. Lawrence (2001)
10.1126/SCIENCE.1062677
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
U. Senftleben (2001)
10.1093/emboj/20.23.6805
Retroviral oncoprotein Tax induces processing of NF‐κB2/p100 in T cells: evidence for the involvement of IKKα
G. Xiao (2001)
10.1016/S0092-8674(01)00599-2
IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development
Y. Cao (2001)
10.1038/35070605
IKKα controls formation of the epidermis independently of NF-κB
Y. Hu (2001)
Preparation of amino acid indolecarboxamides as modulators of NFκB activity
Aventis Pharma (2001)
Preparation of substituted β-carbolines as potential therapeutics in diseases associated with increased IκB kinase activity
Aventis Pharma (2001)
Preparation of benzimidazolecarboxylic acid amino acid amides as IκB kinase inhibitors
Aventis Pharma (2001)
10.1038/ni0302-221
NF-κB at the crossroads of life and death
M. Karin (2002)
10.1016/S1359-6446(02)02309-7
NF-κB: arresting a major culprit in cancer
B. Haefner (2002)
10.1016/S0960-894X(02)00517-6
Structure–Activity Relationship Studies of Ethyl 2-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate: An Inhibitor of AP-1 and NF-κB Mediated Gene Expression
M. Palanki (2002)
10.1074/JBC.M109619200
RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100*
N. Solan (2002)
10.1074/jbc.M200360200
NF-κB as a Therapeutic Target in Multiple Myeloma*
T. Hideshima (2002)
10.4049/jimmunol.168.6.2644
Thalidomide Suppresses NF-κB Activation Induced by TNF and H2O2, But Not That Activated by Ceramide, Lipopolysaccharides, or Phorbol Ester1
S. Majumdar (2002)
10.1182/BLOOD.V99.12.4525
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.
N. Mitsiades (2002)
10.1038/sj.bjp.0704888
The combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro–from cytotoxic synergy to complete inhibition of apoptosis
P. Martinsson (2002)
NF-kappa B: arresting a major culprit in cancer.
B. Haefner (2002)
Sulindac Enhances Tumor Necrosis Factor-α-mediated Apoptosis of Lung Cancer Cell Lines by Inhibition of Nuclear Factor-κB
K. Berman (2002)
10.1016/S1074-7613(02)00423-5
The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways
E. Dejardin (2002)
10.1016/S0092-8674(02)00703-1
Missing Pieces in the NF-κB Puzzle
S. Ghosh (2002)
10.1021/BI0263210
Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation.
J. Cárcamo (2002)
therapeutic implications
Mitsiades (2002)
IκB kinase β inhibitors useful as antiinflammatories
Bayer (2002)
A small molecule inhibitor of IκB kinase β (IKKβ) blocks inflammation and protects joint integrity in in vivo models of arthritis
Roshak (2002)
Vitamin C suppresses TNFα-induced NF-κB activation by inhibiting IκBα phosphorylation
J. M. Carcamo (2002)
Antitumor drug–cyanoguanidine IKK inhibitor combination
Leo Pharma (2002)
Preparation of imidazolylquinolinecarboxaldehyde semicarbazones as IKK modulators
Tularik Inc (2002)
an inhibitor of AP-1 and NF-κB mediated gene expression
Palanki (2002)
Preparation of 5-amino-1Himidazole-4-carboxamides as NF-κB inhibitors
Smithkline Beecham Corp (2002)
Identification of a disease modifying IKK2 inhibitor in rat adjuvant arthritis
Leisten (2002)
A method using cyanoguanidine compounds for modulating NFκB activity and use for the treatment of cancer
Leo Pharma (2002)
Preparation of 2-aminothiophene-3-carboxamides as NF-κB inhibitors
Smithkline Beecham Corp (2002)
10.1016/S0305-7372(03)00082-3
Clinical update: proteasome inhibitors in solid tumors.
H. Lenz (2003)
10.1097/00001813-200306000-00001
Thalidomide analogs as emerging anti-cancer drugs
K. Dredge (2003)
10.1016/S0960-894X(03)00408-6
Novel IKK inhibitors: β-carbolines
A. C. Castro (2003)
10.1002/ART.11131
A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice.
K. McIntyre (2003)
10.1038/nature01648
A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression
V. Anest (2003)
10.1038/nm849
The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion
Lee-Wei Chen (2003)
10.1016/S0022-2836(02)01404-3
TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway
G. Takaesu (2003)
10.1074/jbc.M209677200
BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice*
J. Burke (2003)
10.1016/S0960-894X(02)01046-6
Discovery of novel and selective IKK-beta serine-threonine protein kinase inhibitors. Part 1.
T. Murata (2003)
10.1093/emboj/cdg379
NF‐κB inhibits TNF‐induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death
S. Sakon (2003)
10.1038/nature01576
Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression
Y. Yamamoto (2003)
10.1074/jbc.M211439200
A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts*
N. Kishore (2003)
10.1093/emboj/cdg332
Evidence that reactive oxygen species do not mediate NF‐κB activation
M. Hayakawa (2003)
10.1038/423596a
Signal transduction: A regulator branches out
A. Israël (2003)
10.1002/CHIN.200330163
Discovery of Novel and Selective IKK-β Serine Threonine Protein Kinase Inhibitors. Part 1.
Murata Toshiki (2003)
proteasome inhibitors in solid tumors
Lenz (2003)
A selective IKK-2 inhibitor blocks NF-κBdependent gene expression in IL-1β stimulated synovial fibroblasts
N Kishore (2003)
Preparation of 4,5-dihydro-1Hbenzo[g]indazole-3-carboxamides for treatment of inflammation
Pharmacia Corp (2003)
a regulator branches out
Israel (2003)
prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion
Chen (2003)
Preparation of pyrazolo [4,3-c]quinolines, chromeno [4,3-c] pyrazoles, and analogs for treatment of inflammation
Pharmacia Corp (2003)
Combination of tumor necrosis factor-α with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice
安井 寛 (2004)
Preparation of 2 , 4 - diarylpyridines as I κ B kinase β inhibitors useful as antiinflammatories
T. Murata
Preparation of ureido – carboxamido thiophene as inhibitors of IKK 2 kinase
A. K. Roshak



This paper is referenced by
10.1016/J.EURPOLYMJ.2021.110494
Material, antibacterial and anticancer properties of natural polyphenols incorporated soy protein isolate: A review
Priyanka Rani (2021)
10.1183/16000617.0041-2021
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care
H. Burke (2021)
10.1016/j.drup.2021.100754
Therapeutic strategies to overcome taxane resistance in cancer.
Tuyelee Das (2021)
10.1002/fsn3.2270
Role of Semisulcospira gottschei extract as medicinal food on reflux esophagitis in rats
Hyeon-Hwa Nam (2021)
10.1016/j.jep.2021.113939
Nephroprotective activitiy of Aframomum melegueta seeds extract against diclofenac-induced acute kidney injury: A mechanistic study.
R. M. Abdou (2021)
10.3389/fphar.2021.657080
Combination of Wogonin and Artesunate Exhibits Synergistic anti-Hepatocellular Carcinoma Effect by Increasing DNA-Damage-Inducible Alpha, Tumor Necrosis Factor α and Tumor Necrosis Factor Receptor-Associated Factor 3-mediated Apoptosis
Minting Chen (2021)
10.3390/molecules26092745
Polyphenols Extracted from Shanxi-Aged Vinegar Inhibit Inflammation in LPS-Induced RAW264.7 Macrophages and ICR Mice via the Suppression of MAPK/NF-κB Pathway Activation
Peng Du (2021)
10.1038/s41419-021-03535-9
Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling
Z. Su (2021)
10.1007/978-1-0716-1669-7_16
Methods to Analyze the Roles of TAK1, TRAF6, and NEMO in the Regulation of NF-κB Signaling by RANK Stimulation During Osteoclastogenesis.
G. Swarnkar (2021)
10.1007/s12282-021-01224-1
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin
Xiaozhong Teng (2021)
10.1155/2021/5552088
Natural Products with Inhibitory Activity against Human Immunodeficiency Virus Type 1
Maria S. Serna-Arbeláez (2021)
10.1080/10520295.2021.1905183
Activation of cannabinoid 2 receptors by JWH-133 protects against ovarian ischemia-reperfusion injury in rats
T. Onat (2021)
10.1016/j.chembiol.2021.03.011
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras.
K. Samarasinghe (2021)
10.3390/ijms21103684
Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer
Antja-Voy Hartley (2020)
10.1016/j.arcmed.2020.01.012
Synergistic Apoptotic Effects of Bortezomib and Methylstat on Multiple Myeloma Cells.
Fatma Necmiye Kaci (2020)
10.1021/acs.molpharmaceut.0c00052
Treatment of Lung Cancer by Peptide-Modified Liposomal Irinotecan Endowed with Tumor Penetration and NF-κB Inhibitory Activities.
Yang Hu (2020)
10.1038/s42255-020-00306-2
c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis.
J. Leslie (2020)
10.3389/fmolb.2020.578964
ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?
F. Pagliari (2020)
10.1080/19490976.2020.1859812
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay
Fangcong Dong (2020)
10.3390/nu12040892
Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research
Henna-Maria Uusitupa (2020)
10.3389/fmats.2020.00274
The Mechanisms Underlying the Biological Response to Wear Debris in Periprosthetic Inflammation
M. Couto (2020)
10.1007/978-3-030-37297-2_4
The Roles and Mechanisms of ROS, Oxidative Stress, and Oxidative Damage
Loutfy H. Madkour (2020)
10.1007/s11255-020-02485-z
Vinpocetine reduces cisplatin-induced acute kidney injury through inhibition of NF–κB pathway and activation of Nrf2/ARE pathway in rats
Wenjing Song (2020)
10.1016/j.phrs.2020.105369
Common risk factors and therapeutic targets in obstructive sleep apnea and osteoarthritis: an unexpectable link?
L. Gaspar (2020)
10.3389/fnagi.2020.00068
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
A. Bellucci (2020)
10.3390/metabo10070283
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
S. Steensels (2020)
10.1186/s12974-020-01930-1
Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma
Xiangjun Yang (2020)
10.1007/978-3-030-39855-2_17
The Use of Anti-Inflammatory Agents for Cancer Chemoprevention
Aymeric Monteillier (2020)
10.3389/fvets.2020.586033
Molecular Mechanisms Underlying Protective Role of Quercetin on Copper Sulfate-Induced Nephrotoxicity in Mice
Xinyan Peng (2020)
10.15252/embj.2019103304
Exercise‐induced α‐ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1‐dependent adrenal activation
Yexian Yuan (2020)
10.1016/j.cellimm.2020.104115
TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
C. Nicolau (2020)
10.3390/biom10081131
Structural Features Defining NF-κB Inhibition by Lignan-Inspired Benzofurans and Benzothiophenes
Toan Dao-Huy (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar